» Articles » PMID: 11000248

Long Terminal Repeat Regions from Exogenous but Not Endogenous Feline Leukemia Viruses Transactivate Cellular Gene Expression

Overview
Journal J Virol
Date 2000 Sep 23
PMID 11000248
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

We have previously reported that the long terminal repeat (LTR) region of feline leukemia viruses (FeLVs) can enhance expression of certain cellular genes such as the collagenase IV gene and MCP-1 in trans (S. K. Ghosh and D. V. Faller, J. Virol. 73:4931-4940, 1999). Genomic DNA of all healthy feline species also contains LTR-like sequences that are related to exogenous FeLV LTRs. In this study, we evaluated the cellular gene transactivational potential of these endogenous FeLV LTR sequences. Unlike their exogenous FeLV counterparts, neither nearly full-length endogenous FeLV molecular clones (CFE-6 and CFE-16) nor their isolated LTRs were able to activate collagenase IV gene or MCP-1 expression in transient transfection assays. We had also demonstrated previously that production of an RNA transcript from exogenous FeLV LTRs correlates with their transactivational activity. In the present study, we demonstrate that the endogenous FeLV LTRs do not generate LTR-specific RNA transcripts in the feline embryo fibroblast cell line AH927. Furthermore, infection of AH927 cells by an exogenous FeLV subgroup A virus did not induce production of such LTR-specific transcripts from the endogenous proviral genomes, although the LTR-specific transcripts from the exogenous virus were readily detected. Finally, LTR-specific transcripts were not generated in BALB/3T3 cells transiently transfected with isolated CFE-6 LTR, in contrast to transfections with LTRs from exogenous viruses. Our data thus suggest that the inability of endogenous FeLV LTRs in gene transactivation is not due to cell line specificity or presence of any upstream inhibitory cis-acting element. Endogenous, nonleukemogenic FeLV LTRs, therefore, do not transactivate cellular gene expression, and this property appears to be specific to exogenous, leukemogenic FeLVs.

Citing Articles

Endogenous feline leukemia virus long terminal repeat integration site diversity is highly variable in related and unrelated domestic cats.

Chiu E, McDonald C, Gagne R, Dunkleberger H, Moxcey M, VandeWoude S Retrovirology. 2024; 21(1):3.

PMID: 38347535 PMC: 10863107. DOI: 10.1186/s12977-024-00635-0.


Prevalence of feline leukaemia provirus DNA in feline lymphomas.

Weiss A, Klopfleisch R, Gruber A J Feline Med Surg. 2010; 12(12):929-35.

PMID: 21036089 PMC: 11135535. DOI: 10.1016/j.jfms.2010.07.006.


High prevalence of non-productive FeLV infection in necropsied cats and significant association with pathological findings.

Suntz M, Failing K, Hecht W, Schwartz D, Reinacher M Vet Immunol Immunopathol. 2010; 136(1-2):71-80.

PMID: 20398945 PMC: 7112630. DOI: 10.1016/j.vetimm.2010.02.014.


Identification of LTR-specific small non-coding RNA in FeLV infected cells.

Forman L, Pal-Ghosh R, Spanjaard R, Faller D, Ghosh S FEBS Lett. 2009; 583(8):1386-90.

PMID: 19336234 PMC: 3774839. DOI: 10.1016/j.febslet.2009.03.056.


Leukemia virus long terminal repeat activates NFkappaB pathway by a TLR3-dependent mechanism.

Abujamra A, Spanjaard R, Akinsheye I, Zhao X, Faller D, Ghosh S Virology. 2005; 345(2):390-403.

PMID: 16289658 PMC: 3808874. DOI: 10.1016/j.virol.2005.10.003.

References
1.
Zaiman A, Nieves A, Lenz J . CBF, Myb, and Ets binding sites are important for activity of the core I element of the murine retrovirus SL3-3 in T lymphocytes. J Virol. 1998; 72(4):3129-37. PMC: 109765. DOI: 10.1128/JVI.72.4.3129-3137.1998. View

2.
Choi S, Faller D . The long terminal repeats of a murine retrovirus encode a trans-activator for cellular genes. J Biol Chem. 1994; 269(31):19691-4. View

3.
Medstrand P, Mager D . Human-specific integrations of the HERV-K endogenous retrovirus family. J Virol. 1998; 72(12):9782-7. PMC: 110489. DOI: 10.1128/JVI.72.12.9782-9787.1998. View

4.
Yoshimura F, Wang T, Cankovic M . Sequences between the enhancer and promoter in the long terminal repeat affect murine leukemia virus pathogenicity and replication in the thymus. J Virol. 1999; 73(6):4890-8. PMC: 112532. DOI: 10.1128/JVI.73.6.4890-4898.1999. View

5.
Ghosh S, Faller D . Feline leukemia virus long terminal repeat activates collagenase IV gene expression through AP-1. J Virol. 1999; 73(6):4931-40. PMC: 112537. DOI: 10.1128/JVI.73.6.4931-4940.1999. View